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CERVICAL CANCER:
Improving Access to Screening and Treatment
BY THE NUMBERS 
530,000
Over 530,000 women are 
diagnosed with cervical 
cancer globally each year 
85%
Approximately 85% of all 
cervical cancer occurs in low- 
and middle-income countries 
23/100,000
About 23 women per 100,000 die from 
cervical cancer in sub-Saharan Africa, 
compared to about 3 per 100,000 in 
North America
The Issue
Most cervical cancers are associated with human 
papillomavirus (HPV) infection, which is passed from 
one person to another during sex. The combination 
of HPV vaccination, regular screening tests, and 
treatment will help decrease the number of new 
cases and deaths associated with cervical cancer.
Several screening tests for cervical cancer are 
available in different countries. These tests include 
HPV tests, visual inspection of cervix with acetic 
acid (VIA), and cytology (Pap tests). Screening with 
cytology can be challenging in settings with limited 
health infrastructure. 
In 2013, the World Health Organization released a 
new guideline for the screening and treatment of 
cervical cancer, in which the treatment decision is 
based on screening tests performed. Treatment can 
then be provided immediately after the woman has 
a positive screening test. This new guideline has 
great promise for making screening more accessible 
and allowing quick treatment of pre-cancers in low-
resource settings and hard-to-reach groups. This 
guideline may have implications not only in low- and 
middle-income countries, but potentially in low-
resource settings in the U.S. and its territories where 
new technologies could increase screening and 
treatment coverages.
“There are no magic bullets, but the combination of more effective and 
affordable tools to prevent and treat cervical cancer will help release the 
strain on stretched health budgets, especially in low-income countries, and 
contribute drastically to the elimination of cervical cancer.”
Dr. Nathalie Broutet, WHO cervical cancer expert
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CDC’s Response
Latin America: CDC and local health leaders 
develop training materials to support public health 
workers as they strengthen cervical cancer screening 
programs in Bolivia and El Salvador.
Sub-Saharan Africa: CDC and its partners build on 
current healthcare activities to provide HIV/AIDS 
and cancer screening and treatment services. The 
partnership develops standards, tools, and guidance 
to make data available for planning and improving 
global cervical cancer programs.
Pacific Islands: Since many areas in this region lack 
screening services, CDC and its partners organized 
an expert panel to make recommendations for 
improving screening, including adopting VIA and 
primary HPV testing.
Health professionals from CDC, the Thai National Cancer Institute, and the Thai Ministry of 
Public Health outside a health center in Ubon Ratchatani.
In Thailand: CDC, the Thai Ministry of Public 
Health, and the Thai National Cancer Institute are 
introducing HPV testing to screen for cervical cancer.
Our Partners
 • American Cancer Society
 • Ministries of Heath 
 • Pan American Health Organization
 • Union for International Cancer Control
 • World Health Organization 
For further information, please visit:
 www.cdc.gov/cancer/international/ 
Cervical cancer is a leading cause of cancer deaths in developing countries.
Publications:
Joseph R, Manosoontorn S, Petcharoen N, Sangrajrang 
S, Senkomago V, Saraiya M. Assessing Cervical Cancer 
Screening Coverage Using a Population-Based 
Behavioral Risk Factor Survey-Thailand, 2010. J Womens 
Health (Larchmt). 2015 Dec;24(12):966-8. doi: 10.1089/
jwh.2015.5624. PubMed PMID: 26653868.
Perin DM, Saraiya M, Thompson TD, de Moura L, Simoes 
EJ, Parra DC, Brownson RC. Providers’ knowledge, 
attitudes, and practices related to colorectal cancer 
control in Brazil. Prev Med. 2015 Dec;81:373-9. doi: 
10.1016/j.ypmed.2015.09.021. Epub 2015 Oct 9. PubMed 
PMID: 26441300.
Wang B, He M, Chao A, Engelgau MM, Saraiya M, Wang L, 
Wang L. Cervical Cancer Screening Among Adult Women 
in China, 2010. Oncologist. 2015 Jun;20(6):627-34. doi: 
10.1634/ theoncologist.2014-0303. Epub 2015 May 
8. PubMed PMID: 25956407; PubMed Central PMCID: 
PMC4571778.
Saraiya M, Senkomago V. A door-to-door approach to 
cervical cancer screening. Lancet Glob Health. 2015 
Feb;3(2):e63-4. doi: 10.1016/S2214-109X(14)70367-5. 
PubMed PMID: 25617192; PubMed PMCID: PMC4521385.
National Center for Chronic Disease Prevention and Health Promotion 
Division of Cancer Prevention and Control
